FDA lays out plans for a new review framework for Artificial Intelligence (AI) and machine learning- based devices
July 25, 2019 The Agency hopes a tailored regulatory framework will help promote the development of machine-learning devices and programs, which FDA Commissioner Scott Gottlieb says “have the potential to fundamentally transform the delivery of healthcare.” “As technology and science advance, we can expect to see earlier disease detection, more accurate diagnosis, more targeted therapies … Read more